These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34806117)

  • 1. Lower low-density lipoprotein cholesterol levels are associated with an increased risk of hematoma expansion and ensuing mortality in acute ICH patients.
    Wang Y; Wu J; Gu H; Yang K; Jiang R; Li Z; Zhao X; Wang Y;
    Neurol Sci; 2022 May; 43(5):3121-3129. PubMed ID: 34806117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage.
    Chang JJ; Katsanos AH; Khorchid Y; Dillard K; Kerro A; Burgess LG; Goyal N; Alexandrov AW; Alexandrov AV; Tsivgoulis G
    Atherosclerosis; 2018 Feb; 269():14-20. PubMed ID: 29253643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of LDL-cholesterol <1.8 mmol/L and statin use with the recurrence of intracerebral hemorrhage.
    Lee TC; Leung WC; Ho C; Chiu MW; Leung IY; Wong YK; Roxanna LK; Sum CH; Lui DT; Cheung RT; Leung GK; Chan KH; Teo KC; Lau KK
    Int J Stroke; 2024 Jul; 19(6):695-704. PubMed ID: 38429252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Association of Low-Density Lipoprotein Cholesterol Levels and Systolic Blood Pressure to the Outcome of Intracerebral Hemorrhage: Data from the China Stroke Center Alliance.
    Ding Y; Wang Y; Liu L; Gu H; Yang K; Li Z; Zhao X
    Oxid Med Cell Longev; 2022; 2022():6206315. PubMed ID: 35761874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage.
    Mustanoja S; Strbian D; Putaala J; Meretoja A; Curtze S; Haapaniemi E; Sairanen T; Hietikko R; Sirén J; Kaste M; Tatlisumak T
    Stroke; 2013 Aug; 44(8):2330-2. PubMed ID: 23760210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between preadmission low-density lipoprotein cholesterol concentration and risk of large intracerebral hemorrhage: Results from the Kailuan study.
    Li Z; Hui Y; Sha Z; Liu B; Wang C; Yang F; Zhang W; Gao C; Jiang R
    J Clin Lab Anal; 2022 Dec; 36(12):e24787. PubMed ID: 36441597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage.
    Rodriguez-Luna D; Rubiera M; Ribo M; Coscojuela P; Pagola J; Piñeiro S; Ibarra B; Meler P; Maisterra O; Romero F; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Sep; 42(9):2447-52. PubMed ID: 21799167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematoma Expansion Predictors: Laboratory and Radiological Risk Factors in Patients with Acute Intracerebral Hemorrhage: A Prospective Observational Study.
    Elkhatib THM; Shehta N; Bessar AA
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2177-2186. PubMed ID: 31133486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between non-HDLC and 1-year prognosis in patients with spontaneous intracerebral haemorrhage: a prospective cohort study from 13 hospitals in Beijing.
    Wang Y; Wu J; Wang A; Jiang R; Zhao X; Wang W
    BMJ Open; 2022 Nov; 12(11):e061241. PubMed ID: 36323476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Serum Lipid and Hematoma Expansion after Spontaneous Intracerebral Hemorrhage in Chinese Patients.
    Cai B; Peng L; Wang ZB; Zhang M; Peng B
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104793. PubMed ID: 32224203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.
    Sabatine MS; Wiviott SD; Im K; Murphy SA; Giugliano RP
    JAMA Cardiol; 2018 Sep; 3(9):823-828. PubMed ID: 30073316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicoradiological profile and serum lipid levels of intracerebral hemorrhage in prior statin users.
    Miura K; Yoshii Y; Nakamura Y; Ikeda K
    Intern Med; 2011; 50(13):1385-91. PubMed ID: 21720057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of subjects with very low serum low-density lipoprotein cholesterol and the risk for intracerebral hemorrhage.
    Lee JG; Koh SJ; Yoo SY; Yu JR; Lee SA; Koh G; Lee D
    Korean J Intern Med; 2012 Sep; 27(3):317-26. PubMed ID: 23019397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial.
    Hagiwara N; Kawada-Watanabe E; Koyanagi R; Arashi H; Yamaguchi J; Nakao K; Tobaru T; Tanaka H; Oka T; Endoh Y; Saito K; Uchida T; Matsui K; Ogawa H
    Eur Heart J; 2017 Aug; 38(29):2264-2276. PubMed ID: 28430910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perihematoma cerebral blood flow is unaffected by statin use in acute intracerebral hemorrhage patients.
    Gioia LC; Kate M; McCourt R; Gould B; Coutts SB; Dowlatshahi D; Asdaghi N; Jeerakathil T; Hill MD; Demchuk AM; Buck B; Emery D; Shuaib A; Butcher K;
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1175-80. PubMed ID: 25757757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
    Silverman MG; Ference BA; Im K; Wiviott SD; Giugliano RP; Grundy SM; Braunwald E; Sabatine MS
    JAMA; 2016 Sep; 316(12):1289-97. PubMed ID: 27673306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study.
    Zhao Y; Zhou Y; Zhou H; Gong X; Luo Z; Li J; Sun J; Lou M; Yan S
    Neuroimage Clin; 2023; 39():103502. PubMed ID: 37643520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India.
    Puri R; Mehta V; Iyengar SS; Srivastava P; Yusuf J; Pradhan A; Pandian JD; Sharma VK; Renjen PN; Muruganathan A; Krishnan M; Srinivasan AV; Shetty S; Narasingan SN; Nair DR; Bansal M; Prabhakar D; Varma M; Paliwal VK; Kapoor A; Mukhopadhyay S; Mehrotra R; Patanwala RM; Aggarwal R; Mahajan K; Kumar S; Bardoloi N; Pareek KK; Manoria PC; Pancholia AK; Nanda R; Wong ND; Duell PB
    Curr Vasc Pharmacol; 2022; 20(2):134-155. PubMed ID: 34751121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.